Qol Holdings Co., Ltd.
Matters Related to Controlling Shareholders, etc.
Medipal Holdings Corporation is the company's largest shareholder holding 23.1% of shares. Explains the independence of parent-subsidiary relationships and transaction conditions. Currently no transactions with related parties. Discloses transactions with consolidated subsidiary Medisecao, including pharmaceutical procurement and accounts payable.
Key Figures
- Voting Rights Ownership Ratio: 23.1%
- Transaction Amount with Related Parties: 45,946 million yen
- Accounts Payable at End of Period: 10,540 million yen
AI要約
Relationship with Controlling Shareholders and Transactions
The disclosed matter confirms that Medipal Holdings Corporation, the largest shareholder, owns 23.1% of our shares directly and indirectly. The relationship explains the cooperative ties and independence between the two groups. There are no business constraints from the parent group, and the company operates independently.
Status of Transactions with Related Parties
It is explicitly stated that there are no applicable transactions with related parties. However, transactions with the consolidated subsidiary Medisecao include accounts payable for pharmaceutical procurement, with transaction amounts totaling 45,946 million yen and an end-of-term balance of 10,540 million yen. The transaction conditions are on par with those of ordinary business partners.
Qol Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
